Table 2.
A. | Median | Minimum | Q1 | Q3 | Maximum | IQR | No. of cases | No. of patients |
---|---|---|---|---|---|---|---|---|
Transient recurrent laryngeal nerve injury in % | ||||||||
BABA-ET (16, 33, 34, 36, 54, 65, 66, 69, 80, 85, 103, 109) | 3.7 | 0.0 | 1.4 | 7.3 | 28.0 | 5.9 | 162 | 1,491 |
BABA-RT (21, 22, 29–32, 51, 63, 66, 68, 69, 74, 79, 90, 109) | 3.0 | 0.0 | 2.0 | 6.4 | 19.0 | 4.4 | 77 | 1,554 |
MIVAT (26, 38, 39, 42, 44, 45, 52, 62, 71, 73, 86, 98, 99, 105, 110) | 2.5 | 0.0 | 1.7 | 4.2 | 17.0 | 2.5 | 86 | 1,727 |
TOETVA (14, 18, 19, 23, 43, 61, 91, 93, 102, 106, 107) | 4.0 | 0.0 | 3.1 | 7.1 | 12.5 | 4.0 | 32 | 736 |
RA-ET (25, 27, 35, 92) | 1.1 | 0.0 | 0 | 6.6 | 11.1 | 6.6 | 3 | 84 |
RA-RT (101) | 5.0 | NA | NA | NA | NA | NA | 1 | 20 |
GTET (28, 40, 41, 55, 59, 64, 73, 76, 81, 84) | 5.3 | 0.0 | 3.1 | 6.3 | 15.0 | 3.2 | 85 | 1,921 |
RATS (20, 24, 28, 37, 45, 48, 49, 56, 57, 59, 60, 67, 72, 75–78, 81–84, 86, 89, 94, 95, 97, 100) | 3.3 | 0.0 | 1.8 | 6.0 | 20.5 | 4.2 | 456 | 15,780 |
Standard of care (2, 14, 16, 20, 22, 31, 32, 36, 45, 48, 51, 52, 54, 55, 61, 64, 68, 72, 77, 81, 82, 89, 90, 93, 103, 105, 110) | 3.3 | 0.0 | 0.0 | 8.8 | 19.5 | 8.8 | 172 | 2,908 |
B. | Median | Minimum | Q1 | Q3 | Maximum | IQR | No. of cases | No. of patients |
Permanent recurrent laryngeal nerve injury in % | ||||||||
BABA-ET (16, 34, 36, 54, 65, 66, 69, 80, 85, 103, 109) | 0.0 | 0.0 | 0.0 | 2.1 | 4.3 | 2.1 | 15 | 1,385 |
BABA-RT (21, 22, 29–32, 51, 63, 66, 68, 69, 74, 79, 90, 109) | 0.0 | 0.0 | 0.0 | 0.7 | 0.9 | 0.7 | 5 | 1,554 |
MIVAT (26, 38, 39, 42, 44, 46, 52, 62, 71, 73, 86–88, 98, 99, 105, 110) | 0.0 | 0.0 | 0.0 | 1.5 | 2.9 | 1.5 | 45 | 4,129 |
TOETVA (14, 18, 19, 23, 43, 61, 91, 93, 96, 102, 106, 107) | 0.0 | 0.0 | 0.0 | 1.1 | 3.1 | 1.1 | 6 | 756 |
RA-ET (25, 27, 35, 92) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 84 |
RA-RT (101) | 0.0 | NA | NA | NA | NA | NA | 0 | 20 |
GTET (28, 40, 41, 55, 59, 64, 73, 76, 81, 84) | 0.4 | 0.0 | 0.0 | 1.6 | 6.3 | 1.6 | 11 | 2,033 |
RATS (20, 24, 28, 37, 48, 49, 56, 57, 59, 60, 67, 72, 75, 76, 78, 83, 84, 86, 89, 94, 95, 97, 100, 108) | 0.1 | 0.0 | 0.0 | 0.5 | 1.3 | 0.5 | 59 | 15,756 |
Standard of care (2, 14, 16, 20, 22, 31, 32, 36, 48, 51, 52, 54, 55, 61, 64, 68, 72, 88–90, 93, 103, 105, 108, 110) | 0.4 | 0.0 | 0.0 | 0.9 | 4.0 | 0.9 | 26 | 2,970 |
Q1, first quartile; Q3, third quartile; IQR, interquartile range; NA, not applicable.